A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma.
docetaxel
lung cancer
myositis
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
02
05
2022
received:
14
04
2022
accepted:
03
05
2022
pubmed:
21
5
2022
medline:
19
7
2022
entrez:
20
5
2022
Statut:
ppublish
Résumé
Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non-small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but there have been few published case reports of myositis. Here, we describe a rare case of docetaxel-induced myositis diagnosed based on laboratory data, thigh magnetic resonance imaging (MRI), and electromyography (EEG). A 66-year-old male was admitted for thigh pain and fatigue that onset 1 week prior. He had been diagnosed with stage IVA (cT4N0M1a) NSCLC 3 years ago and had been started on docetaxel (60 mg/m
Identifiants
pubmed: 35595502
doi: 10.1111/1759-7714.14480
pmc: PMC9284182
doi:
Substances chimiques
Docetaxel
15H5577CQD
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2075-2077Informations de copyright
© 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Références
Intern Med J. 2005 Jun;35(6):369-70
pubmed: 15892769
Thorac Cancer. 2022 Jul;13(14):2075-2077
pubmed: 35595502
Anticancer Res. 2005 Jan-Feb;25(1B):523-5
pubmed: 15816622
Curr Rheumatol Rep. 2011 Jun;13(3):208-15
pubmed: 21336621
Indian J Nucl Med. 2020 Jul-Sep;35(3):248-250
pubmed: 33082686
Case Rep Rheumatol. 2015;2015:795242
pubmed: 26257973
Anticancer Drugs. 2018 Jun;29(5):477-481
pubmed: 29561309
Curr Opin Rheumatol. 1994 Nov;6(6):590-4
pubmed: 7865378
J Cancer Res Ther. 2015 Jul-Sep;11(3):664
pubmed: 26458695